Company profilePharmaceutical#116 of 1,318 in Pakistan3 DRAP alerts

ADAMJEE PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 139 brands · 163 molecules

Ranked #2 of 62 companies in Neuro

139 registered products 48 pharmaceutical brands 163 distinct molecules 3 DRAP alerts

Company overview

139
registered products
48
pharmaceutical brands
163
distinct molecules
12
therapeutic classes
3
DRAP alerts

ADAMJEE PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 139 product registrations across 163 distinct molecules. It is the 116th largest registrant in Pakistan by product count, and ranks 2nd of 62 in Neuro. Its portfolio is concentrated in Neuro and Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives. DRAP has issued 3 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ADAMJEE

114 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

84
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202581
20263

Top molecules by brand count

Paracetamol5 brands
Artemether5 brands
Levofloxacin4 brands
Azithromycin4 brands
Omeprazole4 brands
Risperidone3 brands
Mebendazole3 brands
Haloperidol3 brands

Therapeutic classes

Neuro · 15Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 10Antidepressants · 6Antiepileptics · 5Other Analgesics And Antipyretics · 3Quinolone Antibacterials · 3Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 2Antiinflammatory And Antirheumatic Products · 2Blood Glucose Lowering Drugs, Excluding Insulin · 1Anthelmintic · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1Antihistamines For Systemic Use · 1

Conditions treated

Anxiety/Depression/Insomnia · 7Schizophrenia/Psychosis · 5Epilepsy/Convulsion · 2Diarrhoea · 1Parkinson'S Disease · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official121 products · Rs 57.04 – Rs 2,417.69
DVAGO29 products · Rs 22.86 – Rs 651.7
Servaid23 products · Rs 56.56 – Rs 1,333.2
Median across source: Rs 287

Regulatory record

3 alerts in the DRAP feed we track.

Recall Alert: Recall of Substandard “Tovir 0.5mg Tablet” Batch No. 55, Manufactured by M/s
2025-06-19
Recall Alert: Drug Product; Dolor DS 100mg/5mL Suspension (Batch # 1236,1237 and 1238) by
2023-12-06
Drug Product Recall: Indobid Capsules (Batch # 386) by M/s Adamjee Pharmaceuticals (Pvt),L
2021-07-15

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 116 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherAscorbic AcidAtorvastatin
GETZ PHARMA PAKISTAN (PVT) LTD. holds 248 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
Wilshire Laboratories (Private) Limited holds 112 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin

Get the full profile for ADAMJEE

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.